ArticleInternational journal of particle therapy2025
Connecting Visual Perception With Proton Therapy-Induced Optic Damage Using Archetypal Analysis.
Article in International journal of particle therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Radiotherapy can lead to radiation-induced optic neuropathy, with vision loss and visual field deficits related to localized damage to the optic pathways. Accurately quantifying visual field deficits and establishing their spatial relationship with anatomical structures and radiation dose distribution remains a significant challenge. We applied archetypal analysis of visual fields as a novel artificial intelligence approach in oncology to identify distinct, interpretable patterns of visual field loss and to model their spatial evolution over time after pencil beam scanning proton therapy. Methods: Machine learning of standardized automated static visual field perimetry was used to decompose the high-dimensional visual field data into convex combinations of representative visual loss patterns, that is, visual archetypes, at both the eye and patient levels. Associations between archetype proportions and radiation dose metrics were evaluated using linear regression, stratified by baseline visual field to account for pre-existing deficits. Results: In 236 patients, 7 archetypal patterns of visual field loss were identified, including tunnel vision, temporal hemianopia, and diffuse full-field loss. More severe patterns were more frequently observed in patients with meningiomas and pituitary adenomas. Longitudinal analysis revealed an annual reduction of 1.9% in the normal visual field archetype in patients with no-to-mild baseline deficits and 9.7% in those with moderate deficits. Dose-archetype associations were clinically significant after adjusting for baseline deficits. Each 1 Gy increase in minimum chiasm dose was associated with a 0.2% decrease in the normal vision archetype. Conclusion: This is the first application of archetypal analysis for predicting radiation-induced optic neuropathy. It enables spatially grounded reconnection between patient perception and radiation damage along optic pathways. This approach offers new mechanistic insights into optic pathway injury towards voxel-level correlation between radiation dose and functional loss and supports data-driven personalization of radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.